Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target.
Credit Suisse Upgrades National Health Investors to Neutral, Raises Price Target to $58
Credit Suisse analyst Omotayo Okusanya upgrades National Health Investors (NYSE:NHI) from Underperform to Neutral and raises the price target from $47 to $58.